PM Modi chairs meeting with Nadda to review TB elimination campaign progress
New Delhi: Prime Minister Narendra Modi convened a meeting on Tuesday to assess the progress of the tuberculosis elimination campaign. Union Health Minister
JP Nadda
and other leaders attended.
The Government of India has implemented various focused strategies under its
National Tuberculosis Elimination Programme
(NTEP) to tackle this significant burden.
These key initiatives under NTEP aim to strengthen diagnosis, treatment, and prevention efforts, accelerating progress toward a TB-free India.
In 2020, the Government of India renamed the Revised National Tuberculosis Control Program (RNTCP) the National TB Elimination Program (NTEP).
This reflects India's goal to eliminate tuberculosis (TB) by 2025, five years before the global target of 2030, according to the release.
According to WHO's Global TB Report, India has made significant progress in fighting tuberculosis. Under the National Tuberculosis Elimination Programme (NTEP), the incidence rate of TB cases has dropped by nearly 17.7 per cent, from 237 cases per 1 lakh people in 2015 to 195 in 2023.
TB-related deaths have also reduced, falling from 28 to 22 per 1 lakh people during the same period, as stated in the release earlier.
The NTEP follows the National Strategic Plan (2017-2025), focusing on four key actions: Detect - Treat - Prevent - Build (DTPB) to control and eliminate TB in India.
To eliminate TB by 2025, the NTEP programme achieved the highest-ever number of
case notifications
, reporting 25.5 lakh TB cases in 2023 and 26.07 lakh cases in 2024. It is the first-ever Indigenous TB burden mathematical model that estimates state-wise TB.
The programme also provided incentives for ASHAS, TB Champions & Caregivers, thus strengthening patient support systems. The programme focused on the high-risk group and found 3 lakh additional cases via house-to-house screening.
560 colleges supported TB detection & research, also regular surveys, drug sales tracking, and under-reporting assessments conducted, also collaboration with ministries, industries, NGOS & technical bodies also done, as stated in a press release.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
4 hours ago
- NDTV
WHO Is Finalising A New Treaty To Prep For The Next Pandemic, But US Isn't Signing
On March 20, 2025, members of the World Health Organization adopted the world's first pandemic agreement, following three years of 'intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.' The U.S., however, did not participate, in part because of its intention to withdraw from the WHO. Global health experts are hailing the agreement as a historic moment. What does the agreement mean for the world, and how can it make everyone safer and more prepared for the next pandemic? The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, and the significance of the U.S.'s absence from it. What will the pandemic agreement do? The accord will bolster pandemic preparation within individual countries and around the world. Countries signing onto the agreement are committing to improve their disease surveillance and grow their heath care workforces, strengthen their regulatory systems and invest in research and development. It encourages countries to strengthen their health regulations and infrastructure, improve communication with the public about pandemics and increase funding for preparation and response efforts. It also includes new mechanisms for producing and distributing vaccines and other essential countermeasures. Finally, it encourages countries to coordinate their responses and share information about infectious diseases and intellectual property so that vaccines and other essential countermeasures can be made available more quickly. The agreement will take effect once enough countries ratify it, which may take several years. Why isn't the US involved? The Biden administration was broadly supportive of a pandemic agreement and was an active participant in negotiations. Prior to Donald Trump's reelection, however, Republican governors had signed a letter opposing the treaty, echoing a conservative think tank's concerns about U.S. sovereignty. The U.S. withdrew from negotiations when President Trump signed an executive order to withdraw from the WHO on the day he was inaugurated for his second term. Why could the lack of US involvement be beneficial for the world? The lack of U.S. involvement likely resulted in a much more equitable treaty, and it is not clear that countries could have reached an agreement had the U.S. continued to object to key provisions. It was only once the U.S. withdrew from the negotiations that an agreement was reached. The U.S. and several other wealthy countries were concerned with protecting their pharmaceutical industry's profits and resisted efforts aimed at convincing pharmaceutical companies to share the knowledge, data and intellectual property needed for producing new vaccines and other essential countermeasures. Other negotiators sought greater access to vaccines and other treatments during a pandemic for poorer countries, which often rely on patented technologies from global pharmaceutical companies. While most people in wealthy countries had access to COVID-19 vaccines as early as 2021, many people in developing countries had to wait years for vaccines. How could the agreement broaden access for treatments? One of the contentious issues in the pandemic agreement has to do with how many vaccines manufacturers in each country must share in exchange for access to genetic sequences to emerging infectious diseases. Countries are still negotiating a system for sharing the genetic information on pathogens in return for access to vaccines themselves. It is important that researchers can get these sequences to make vaccines. And, of course, people need access to the vaccines once they are developed. Still, there are many more promising aspects of the agreement for which no further negotiations are necessary. For instance, the agreement will increase global vaccine supply by increasing manufacturing around the world. The agreement also specifies that countries and the WHO should work together to create a mechanism for fairly sharing the intellectual property, data and knowledge needed to produce vaccines and other essential health products. If financing for new innovation requires equitable access to the new technologies that are developed, many people in poor countries may get access to vaccines much more quickly in the next pandemic. The agreement also encourages individual countries to offer sufficient incentives for pharmaceutical companies to extend access to developing countries. If countries implement these changes, that will benefit people in rich countries as well as poor ones. A more equitable distribution of vaccines can contain the spread of disease, saving millions of lives. What more should be done, and does the US have a role to play? In my view, the best way to protect public health moving forward is for countries to sign on to the agreement and devote more resources to global health initiatives. This is particularly important given declining investment and participation in the WHO and the contraction of other international health initiatives, such as USAID. Without international coordination, it will become harder to catch and address problems early enough to prevent epidemics from becoming pandemics. It will also be imperative for member countries to provide funding to support the agreement's goals and secure the innovation and access to new technologies. This requires building the basic health infrastructure to ensure shots can get into people's arms.
Indian Express
5 hours ago
- Indian Express
Why Ayushman Bharat payments are stalled in Jharkhand
The promise of Ayushman Bharat seems to be unravelling in Jharkhand. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY), meant to provide affordable and accessible healthcare to low-income families, was launched by Prime Minister Narendra Modi in Ranchi in 2018. More than 23 lakh people in Jharkhand have availed treatment under the scheme since then. But pending payments to the tune of Rs 190 crore and mounting are jeopardising the future of Ayushman Bharat in Jharkhand. Some 212 hospitals have not received payments since last June, and the rest 538 hospitals empanelled under the scheme await reimbursement since February this year. Hospitals in the districts of Hazaribagh, Koderma, Palamu, and Deoghar have already pulled out of the scheme citing the hold up in payments. And this may just be the beginning. An ambitious scheme AB PM-JAY is the largest health insurance scheme in the world. It provides a cover of Rs 5 lakhs per family per year to eligible beneficiaries for hospitalisation expenses in both government and empanelled private hospitals. At the moment, some 750 hospitals in Jharkhand are registered under the scheme, according to the Association of Healthcare Providers of India (AHPI) and the Indian Medical Association (IMA). Current eligibility extends to the bottom 40% households, which is calculated based on deprivation and occupational data from the Socio-Economic Caste Census of 2011. The Prime Minister last year announced that coverage will soon be extended to all citizens aged 70 years and above. The cost of implementation of AB PM-JAY is shared between the Central and State Governments in a 60:40 ratio. According to Jharkhand officials, around 28 lakh families (some 1.5 crore people) are enrolled under AB PM-JAY in Jharkhand, with another 38 lakh families (roughly 2 crore people) covered through the state-run Mukhyamantri Swasthya Bima Yojana, for which the state bears the full cost. The way these schemes work is that beneficiaries are issued insurance cards, using which they can avail healthcare services in empanelled hospitals. These hospitals are then reimbursed on actuals by the government from the funds allocated under the scheme. Officials have confirmed to The Indian Express that there is no shortage of funds under the AB PM-JAY scheme, with Rs 2,284 crore allocated to the hospitals over the last 7 years. The problem is that beginning last year, the disbursement of these funds to hospitals has stalled. This is due to two main reasons. IRREGULARITIES & ED CASES: Last year, the National Anti Fraud Unit (NAFU), using AI, flagged 212 hospitals — 180 private and 32 government — for alleged irregularities in the implementation of Ayushman Bharat. These hospitals were subsequently placed 'on hold', which means that the further disbursement of funds to them was halted until the Enforcement Directorate (ED) completes its investigation. In April 2025, the ED conducted raids at 21 locations across Jharkhand, including prominent hospitals in Ranchi localities like Ashok Nagar, PP Compound, and Lalpur. These raids were linked to a CAG audit, which flagged alleged fraud, including the existence of ghost beneficiaries. The ED investigation is ongoing. Meanwhile, funds to the other 538 hospitals empanelled under the Ayushman Bharat scheme in Jharkhand, have also been stopped since earlier this year. This has been at the heart of the growing frustration in the state with the scheme. 'The ED is investigating 212 hospitals, till then the remaining hospitals also have to suffer,' said Dr Sayeed Ahmad Ansari, president of the AHPI, Jharkhand. Ansari and others have questioned why the hospitals not flagged by NAFU have also had their funding stopped. On Tuesday (June 3), Jharkhand Health Minister Irfan Ansari chaired a meeting with representatives of at least 200 hospitals and other senior officials. After the meeting he announced that the process to release funds to hospitals not under the ED scanner will be started at the earliest. A NEW GLITCHY PORTAL: Dr Anant Sinha, senior surgeon and president of the Jharkhand chapter of the IMA-affiliated Hospital Board blamed the stalling of payments on the introduction of a new web portal earlier this year. 'We were told the things would be streamlined by March… We are still waiting,' he said. Sinha is talking about HEM 2.0 which replaced the older Health Entitlement Management portal, a digital platform used for identifying, verifying, and managing beneficiaries under health schemes like AB PM-JAY. Doctors and officials claim that payments are held up at multiple stages, mostly because of procedural changes and technical shifts in the new web portal. Much of the current logjam is attributed to the launch of HEM 2.0, and the increased insurance cap which accompanied its introduction in February. (The Jharkhand government increased the insurance coverage from Rs 5 lakh to Rs 15 lakh per family under the Mukhyamantri Abua Swasthya Suraksha Yojana, the state's co-branded version of AB PM-JAY, which has also expanded coverage to 38 lakh families in Jharkhand, including all ration card holders in the state). Critics say HEM 2.0 lacks essential filters which has led to backlogs and missing data. As per the officials, another problem is that the payment follows FIFO (First In, First Out) mode where bills are cleared in the order they were approved, not the order in which they are filed. This rigid flow has further slowed claim settlements. A political slugfest Dr Sinha said that non-payment of Ayushman Bharat dues has meant that he has been unable to pay his staff since March. He added that if the payments did not come in, he would stop taking Ayushman Bharat card holders as patients. 'The real loss is to the government and the public,' Sinha warned. AHPI and IMA have claimed that 60 of the 212 NAFU-flagged hospitals have shut down under financial duress. More closures may be on the way if the situation is not sorted out soon. This has made Ayushman Bharat a growing political issue in Jharkhand as well. Babulal Marandi, the state chief of the BJP and the Leader of the Opposition in the state Assembly, accused Hemant Soren's government of failing to implement the Ayushman Bharat scheme in the state. 'Ayushman Bharat, launched by PM Modi from Jharkhand, is now barely functional here,' Marandi said. He claimed that over 500 hospitals have not been paid since February 25, and more than 200 haven't received dues for the past 10 months. 'Hospitals are shutting Ayushman services. Patients are being left in the lurch,' he said. Health Minister Ansari, while countering the former CM's allegations, said that until the ongoing investigation is completed, no hospital will be paid. Ansari claimed that several hospitals linked to BJP leaders are under scrutiny. 'Let me be clear — those misusing the Ayushman scheme for corruption will not be spared,' he said. Shubham Tigga hails from Chhattisgarh and studied journalism at the Asian College of Journalism. He previously reported in Chhattisgarh on Indigenous issues and is deeply interested in covering socio-political, human rights, and environmental issues in mainland and NE India. Presently based in Pune, he reports on civil aviation, other transport sectors, urban mobility, the gig economy, commercial matters, and workers' unions. You can reach out to him on LinkedIn ... Read More
Hans India
7 hours ago
- Hans India
AB-PMJAY, Jan Aushadhi Kendras boosting healthcare for middle class in last 11 years
New Delhi: Flagship scheme like the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and the Jan Aushadhi Kendras under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has significantly enhanced healthcare for middle class in the last 11 years, according to an official statement issued on Thursday. 'Healthcare in India has seen a quiet but far-reaching shift in the last eleven years. Through a blend of targeted public schemes and digital reach, the Government has made quality healthcare both affordable and accessible for millions, especially the middle class,' the statement said. With more than 41.02 crore Ayushman Cards created in 33 States and Union Territories, as of May 30, AB-PMJAY has emerged as one of the world's largest publicly funded health assurance schemes. The scheme has enabled 8.59 crore hospital admissions worth Rs 1,19,858 crore, ensuring access to secondary and tertiary care without pushing families into debt, the statement said. Further, with the number of Jan Aushadhi Kendras rising to 16,469, as of May 30, from just 80 in 2014, the PMBJP brought essential medicines within reach of the common citizen. These outlets offer medicines that cost 50 to 80 per cent less than branded options, with strict quality standards ensured through WHO-GMP certified suppliers. The scheme serves around 10 to 12 lakh people daily, and cumulative savings over the last eleven years are estimated to be more than Rs 38,000 crore, the statement said. The product range now includes 2,110 medicines, including for chronic conditions like diabetes or heart disease, and 315 surgical products, covering all major treatments, cutting down financial stress for millions of families, especially the middle class. 'From free hospitalisation for senior citizens to low-cost medicines available nationwide, people today have better control over their health expenses. The digital backbone supporting these schemes has made enrolment, access, and tracking easier than ever. This change has allowed the middle class to benefit from savings on medicines, timely treatment, and greater medical security without bureaucratic hassles,' the statement said. 'Over the past eleven years, the government has shown unwavering commitment to uplifting the middle class in meaningful ways. The policies and reforms introduced have not only eased everyday challenges but also strengthened financial security, housing, healthcare, and skill development,' it added.
